Organization
Bristol-Myers Squibb, Princeton, NJ, United States
3 abstracts
Abstract
ABATACEPT IMPROVES FATIGUE, ACTIVITY LIMITATION AND QUALITY OF LIFE IN METHOTREXATE-NAÏVE PATIENTS WITH EARLY RA AND POOR PROGNOSTIC FACTORS Org: UZ Gasthuisberg, KU Leuven, Leuven, Belgium, Klinikum Eilbek, Hamburg, Germany, Johns Hopkins Univ School of Medicine, Baltimore, MD, United States, Institut de Rhumatologie de Montreal, Montreal, QC, Canada, Bristol-Myers Squibb, Princeton, NJ, United States,
Abstract
ASSOCIATION OF THE RHEUMATOID ARTHRITIS PROGNOSTIC FACTORS ANTI-CITRULLINATED PEPTIDE ANTIBODIES, RHEUMATOID FACTOR AND EROSIONS WITH DISEASE ACTIVITY AND WORK PRODUCTIVITY Org: Bristol-Myers Squibb, Princeton, NJ, United States, Brigham and Women's Hospital, Boston, United States,
Abstract
ASSOCIATION OF RADIOGRAPHIC OUTCOMES WITH LOW DISEASE ACTIVITY AND REMISSION AND SUSTAINABILITY OF RESPONSE WITH SUBCUTANEOUS ABATACEPT OR ADALIMUMAB: 2-YEAR RESULTS FROM THE AMPLE TRIAL Org: University of Texas Southwestern Medical Center, Dallas, TX, University of Colorado Denver, Brigham & Women's Hospital, Boston, Bristol-Myers Squibb, Princeton, NJ, United States, Brigham and Women's Hospital, Boston, MA,